June 10, 2022 This Week in Cardiology Podcast

June 10, 2022 This Week in Cardiology Podcast

More ISCHEMIA controversy, health Insurance and CV outcomes, testosterone, and flawed observational studies are the topics discussed by John Mandrola, MD in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic

I – More Ischemia Controversy

- Data Concerns Mount Despite ISCHEMIA Substudy Correction https://www.medscape.com/viewarticle/974974

- ISCHEMIA Substudy Data Just Don't Add Up, Cardiac Surgeons Say https://www.medscape.com/viewarticle/974107

- Initial Invasive or Conservative Strategy for Stable Coronary Disease https://www.nejm.org/doi/full/10.1056/nejmoa1915922

- Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.120.049755

- Link to Bakaeen and Sabik Second letter (agree to terms to download the letter): https://protect-us.mimecast.com/s/nfDdCwp5G6HLjLO9GHV9Cnm?domain=wetransfer.com

II – Health Insurance and CV outcomes

- Medicaid Expansion: Good First Step, but No Panacea for CV Care https://www.medscape.com/viewarticle/975141

- Health Care Access and Management of Cardiovascular Risk Factors Among Working-Age Adults With Low Income by State Medicaid Expansion Status https://jamanetwork.com/journals/jamacardiology/article-abstract/2793120

- Rand Link https://www.rand.org/pubs/reports/R3055.html

- The Oregon Health Insurance Experiment https://www.healthaffairs.org/do/10.1377/hpb20150716.236899/full/

- Effect of Health Insurance in India: A Randomized Controlled Trial https://www.nber.org/papers/w29576

III – Testosterone

- Jury Still Out on Cardiovascular Safety of Testosterone https://www.medscape.com/viewarticle/975273

- Adverse cardiovascular events and mortality in men during testosterone treatment: an individual patient and aggregate data meta-analysis https://doi.org/10.1016/S2666-7568(22)00096-4

- Adverse events associated with testosterone administration. https://www.nejm.org/doi/full/10.1056/NEJMoa1000485

IV – Voting and Mortality

- Blue Counties Enjoy Dramatic Mortality Edge https://www.medscape.com/viewarticle/975217

- Political environment and mortality rates in the United States, 2001-19: population based cross sectional analysis https://www.bmj.com/content/377/bmj-2021-069308

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine https://www.medscape.com/features/public/machine

The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington

Questions or feedback, please contact news@medscape.net

Episoder(402)

Dec 08 2023 This Week in Cardiology

Dec 08 2023 This Week in Cardiology

Three aspects of the recent AF guideline documents and a possible new treatment of POTS are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare prof...

8 Des 202328min

Dec 01 2023 This Week in Cardiology

Dec 01 2023 This Week in Cardiology

More from AHA including SGLT2 inhibitors, blood transfusion after MI; cracks in the armor of Factor XI inhibitors; and renal denervation are the topics John Mandrola, MD, covers in this week's podcast...

1 Des 202327min

Nov 17 2023 This Week in Cardiology

Nov 17 2023 This Week in Cardiology

An AHA Recap: SELECT, ORBITA2, and ARTESIA are the trials John Mandrola, MD, reviews in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or...

17 Nov 202325min

Nov 10 2023 This Week in Cardiology

Nov 10 2023 This Week in Cardiology

Renal denervation, a potential deadly decision in the ED, GLP-1 agonists, and an AHA preview are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare...

10 Nov 202324min

Nov 03 2023 This Week in Cardiology

Nov 03 2023 This Week in Cardiology

Tricuspid regurgitation therapy, two more left atrial appendage trials, and reflections on being too soft on medical science are the topics John Mandrola, MD, discusses in this week's podcast. This po...

3 Nov 202326min

Oct 27 2023 This Week in Cardiology

Oct 27 2023 This Week in Cardiology

More on the Million Hearts RCT, ENRICH AF, TAVI vs SAVR, the Partner 3 and Evolut-low-risk trials, and myocardial viability are the topics John Mandrola, MD, covers in this week's podcast. This podcas...

27 Okt 202329min

Oct 20 2023 This Week in Cardiology

Oct 20 2023 This Week in Cardiology

Listener feedback, oral anticoagulation in patients with ICH, an example of statistical significance but not clinical significance, and statins and diabetes are the topics John Mandrola, MD, discusses...

20 Okt 202326min

Oct 13 2023 This Week in Cardiology

Oct 13 2023 This Week in Cardiology

Three stories regarding GLP-1 agonists, imaging during PCI, and the power of sham controls in procedure trials are the topics John Mandrola, MD, covers in this week's podcast. This podcast is intended...

13 Okt 202321min

Populært innen Vitenskap

fastlegen
tingenes-tilstand
jss
rekommandert
forskningno
sinnsyn
villmarksliv
rss-paradigmepodden
liberal-halvtime
rss-nysgjerrige-norge
tomprat-med-gunnar-tjomlid
nevropodden
fjellsportpodden
diagnose
tidlose-historier
kvinnehelsepodden
rss-inn-til-kjernen-med-sunniva-rose
psykopoden
dekodet-2
rss-rekommandert